Advertisement

Hormones

, Volume 9, Issue 2, pp 103–108 | Cite as

Increasing world incidence of thyroid cancer: Increased detection or higher radiation exposure?

  • Leonard Wartofsky
Review

Key words

Follicular thyroid adenoma Follicular thyroid carcinoma Irradiation Thyroid cancer 

References

  1. 1.
    Davies L, Welch HG, 2006 Increasing incidence of thyroid cancer in the United S tates, 1973–2002. JAMA 295: 2164–2167.CrossRefGoogle Scholar
  2. 2.
    Jemal A, Siegel R, Ward E, et al, 2006 Cancer S tatistics, CA Cancer J Clin 56: 106–130.CrossRefGoogle Scholar
  3. 3.
    Ito J, Noguchi S, Murakami T, Noguchi A, 1980 Factors affecting the prognosis of patients with carcinoma of the thyroid. Surg Gynecol Obstet 150: 539–544.PubMedGoogle Scholar
  4. 4.
    Kesmodel SB, Terhune KP, Canter RJ, et al, 2003 The diagnostic dilemma of follicular variant of papillary thyroid carcinoma. Surgery 134: 1005–1012.CrossRefGoogle Scholar
  5. 5.
    Ain KB, 1995 Papillary thyroid carcinoma. Etiology, assessment, and therapy. Endocrinol Metab Clin North Am 24: 711–760.CrossRefGoogle Scholar
  6. 6.
    Schlumberger MJ, 1998 Papillary and follicular thyroid carcinoma. N Engl J Med 338: 297–306.CrossRefGoogle Scholar
  7. 7.
    Robbins J, Merino MJ, Boice JD Jr, et al, 1991 Thyroid cancer: a lethal endocrine neoplasm. Ann Intern Med 115: 133–147.CrossRefGoogle Scholar
  8. 8.
    Hay ID, 1990 Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 19: 545–576.CrossRefGoogle Scholar
  9. 9.
    Kashima K, Yokoyama S, Noguchi S, et al, 1998 Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma. Thyroid 8: 197–202.CrossRefGoogle Scholar
  10. 10.
    Loh KC, Greenspan FS, Dong F, Miller TR, Yeo PP, 1999 Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 84: 458–463.CrossRefGoogle Scholar
  11. 11.
    Mechler C, Bounacer A, Suarez H, et al, 2001 Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring R ET/PTC rearrangements. Br J Cancer 85: 1831–1837.CrossRefGoogle Scholar
  12. 12.
    Uchino S, Noguchi S, Kawamoto H, et al, 2002 Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. World J Surg 26: 897–902.CrossRefGoogle Scholar
  13. 13.
    Larson SD, Jackson LN, Riall TS, et al, 2007 Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway. J Am Coll Surg 204: 764–775.CrossRefGoogle Scholar
  14. 14.
    Pal T, Vogl FD, Chappuis PO, et al, 2001 Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study. J Clin Endocrinol Metab 86: 5307–5312.CrossRefGoogle Scholar
  15. 15.
    Chen AY, Levy L, Goepfert H, Brown BW, Spitz MR, Vassilopoulou-Sellin R, 2001 The development of breast carcinoma in women with thyroid carcinoma. Cancer 92: 225–231.CrossRefGoogle Scholar
  16. 16.
    Garner CN, Ganetzky R, Brainard J, et al, 2007 Increased prevalence of breast cancer among patients with thyroid and parathyroid disease. Surgery 142: 806–813.CrossRefGoogle Scholar
  17. 17.
    Polednak AP, 1994 Trends in cancer incidence in Connecticut 1935–1991. Cancer 74: 2863–2872.CrossRefGoogle Scholar
  18. 18.
    Goodman MT, Yoshizawa CN, Kolonel LN, 1988 Descriptive epidemiology of thyroid cancer in Hawaii. Cancer 61: 1272–1281.CrossRefGoogle Scholar
  19. 19.
    Whelan SL, Parkin DM, Masuyer E, 1990 Patterns of cancer in five continents. IARC Sci Publ 102: 1–159.Google Scholar
  20. 20.
    Ferlay J, Bray F, Pisani P, Parkin DM 2004 Globocan 2002: Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5, Lyon: IARC Press.Google Scholar
  21. 21.
    Franceschi S, LaVecchia C, Bidoli E, 1998 High incidence of thyroid cancer in central Italy. Int J Cancer 77: 481–482.CrossRefGoogle Scholar
  22. 22.
    Hrafnkelsson J, Jonasson JG, Sigurdsson G, Sigvaldason H, Tulinius H, 1988 Thyroid cancer in Iceland 1955–1984. Acta Endocrinol (Copenh) 118: 566–572.Google Scholar
  23. 23.
    Liu S, Semenciw R, Ugnat AM, Mao Y, 2001 Increasing thyroid cancer incidence in Canada, 1970–1996: time trends and age-period-cohort effects. Br J Cancer 85: 1335–1339.CrossRefGoogle Scholar
  24. 24.
    Hodgson NC, Button J, Solorzano CC, 2004 Thyroid cancer: is the incidence still increasing? Ann Surg Oncol 11: 1093–1097.CrossRefGoogle Scholar
  25. 25.
    Burgess JR, 2002 Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma (1982–1987). Thyroid 12: 141–149.CrossRefGoogle Scholar
  26. 26.
    Truong T, Rougier Y, Dubourdieu, et al, 2007 Time trends and geographic variations for thyroid cancer in New Caledonia, a very high incidence area (1985–1999). Eur J Cancer Prev 16: 62–70.CrossRefGoogle Scholar
  27. 27.
    Colonna M, Grosclaude P, Remontet L, et al, 2002 Incidence of thyroid cancer in adults recorded by French cancer registries (1978–1997). Europ J Cancer 38: 1762–1768.CrossRefGoogle Scholar
  28. 28.
    Reynolds RM, Weir J, Stockton DL, Brewster DH, Sandeep TC, Strachan MW, 2005 Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Endocrinol (Oxf) 62: 156–162.CrossRefGoogle Scholar
  29. 29.
    Dijkstra B, Prichard RS, Lee A, et al, 2007 Changing patterns of thyroid carcinoma. Irish J Med Sci 176: 87–90.CrossRefGoogle Scholar
  30. 30.
    Cardis E, Kesminierne A, Ivanov V, et al, 2005 Risk of thyroid cancer after exposure to 131-I in childhood. J Natl Cancer Inst 97: 724–732.CrossRefGoogle Scholar
  31. 31.
    Figge JJ, Jennings T, Gerasimov G, Kartel N, Yarmolinsky D, Ermak G, 2006 Radiation induced thyroid cancer. In Thyroid Cancer: A Comprehensive Guide to Clinical Management, L. Wartofsky and D. Van Nostrand (Eds), Humana Press, Totowa, NJ; pp, 63–83.CrossRefGoogle Scholar
  32. 32.
    Jacob P, Kenigsberg Y, Zvonova I, et al, 1999 Childhood exposure due to the Chernobyl accident and thyroid cancer risk in contaminated areas of Belarus and Russia. Br J Cancer 80: 1461–1469.CrossRefGoogle Scholar
  33. 33.
    Kerber RA, Till JE, Simon SL, et al, 1993 A cohort study of thyroid disease in relation to fallout from nuclear weapons testing. JAMA 270: 2076–2082.CrossRefGoogle Scholar
  34. 34.
    Conard RA, Dobyns BM, Sutow WW, 1970 Thyroid neoplasia as late effect of exposure to radioactive iodine in fallout. JAMA 214: 316–324.CrossRefGoogle Scholar
  35. 35.
    Parker N, Belsky JL, Yamamoto T, Kawamoto S, Keehn RJ, 1974 Thyroid carcinoma after exposure to atomic radiation: a continuing survey of a fixed population, Hiroshima and Nagasaki, 1958–1971. Ann Intern Med 80: 600–604.CrossRefGoogle Scholar
  36. 36.
    Imaizumi M, Usa T, Tominaga T, et al, 2006 Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55–58 years after radiation exposure. JAMA 295: 1011–1022.CrossRefGoogle Scholar
  37. 37.
    Davis S, Kopecky KJ, Hamilton TE, Onstad L, Hanford Thyroid Disease Study Team, 2004 Thyroid neoplasia, autoimmune thyroiditis, and hypothyroidism in persons exposed to iodine 131 from the Hanford nuclear site. JAMA 292: 2600–2613.CrossRefGoogle Scholar
  38. 38.
    Hahn K, Schnell-Inderst P, Grosche B, Holm LE, 2001 Thyroid cancer after diagnostic administration of iodine-131 in childhood. Radiat Res 156: 61–70.CrossRefGoogle Scholar
  39. 39.
    Dickman PW, Holm LE, Lundell G, Boice JD Jr, Hall P, 2003 Thyroid cancer risk after thyroid examination with 131-I: a population-based cohort study in Sweden. Int J Cancer 106: 580–587.CrossRefGoogle Scholar
  40. 40.
    Holm LE, Hall P, Wiklund K, et al, 1991 Cancer risk after iodine-131 therapy for hyperthyroidism. J Natl Cancer Inst 83: 1072–1077.CrossRefGoogle Scholar
  41. 41.
    Sarne D, Schneider AB, External radiation and thyroid neoplasia. Endocrinol Metab Clin North Am 25: 181–196.Google Scholar
  42. 42.
    Ron E, Kleinerman RA, Boice JD Jr, LiVolsi VA, Flannery JT, Fraumeni JF Jr, 1987 A population-based case-control study of thyroid cancer, J Natl Cancer Inst 79: 1–12.PubMedGoogle Scholar
  43. 43.
    Favus MJ, Schneider AB, Stachura ME, et al, 1976 Thyroid cancer occurring as a late consequence of head-and-neck irradiation: Evaluation of 1056 patients. N Engl J Med 294: 1019–1025.CrossRefGoogle Scholar
  44. 44.
    Mellemgaard A, From G, Jorgensen T, Johansen C, Olsen JH, Perrild H, 1998 Cancer risk in individuals with benign thyroid disorders. Thyroid 8: 751–754.CrossRefGoogle Scholar
  45. 45.
    Herraiz M, Barbesino G, Gaquin W, et al, 2007 Prevalence of thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations. Clin Gastroenterol Hepatol 5: 367–373.CrossRefGoogle Scholar
  46. 46.
    Kent L, McBride R, McConnell R, Neugut AI, Bhagat G, Green PH, 2006 Increased risk of papillary thyroid cancer in celiac disease. Dig Dis Sci 51: 1875–1877.CrossRefGoogle Scholar
  47. 47.
    Guignard R, Truong T, Rougier Y, Baron-Dubourdieu D, Guenel P, 2007 Alcohol drinking tobacco smoking, and anthropometric characteristics as risk factors for thyroid cancer: a countrywide case-control study in New Caledonia. Am J Epidemiol 166: 1140–1149.CrossRefGoogle Scholar
  48. 48.
    Hovens GC, Stokkel MP, Kievit J, et al, 2007 A ssociations of serum thyrotropin concentrations with recurrence and death in differentiated thyroid cancer. J Clin Endocrinol Metab 92: 2610–2615.CrossRefGoogle Scholar
  49. 49.
    Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA, 2006 Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle-aspiration. J Clin Endocrinol Metab 91: 4295–4301.CrossRefGoogle Scholar
  50. 50.
    Haymart MR, Repplinger DJ, Leverson GE, et al, 2007 Higher serum TSH level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab 93: 809–814.CrossRefGoogle Scholar

Copyright information

© Hellenic Endocrine Society 2010

Authors and Affiliations

  1. 1.Department of MedicineWashington Hospital CenterWashington, DCUSA
  2. 2.Uniformed Services University of the Health SciencesBethesdaUSA
  3. 3.Georgetown University School of MedicineWashington, D.C.USA

Personalised recommendations